In a report released today, Charles Peters from Raymond James maintained a Buy rating on Health Insurance Innovations (HIIQ), with a price target of $50. The company’s shares opened today at $35.
According to TipRanks.com, Peters is a 4-star analyst with an average return of 7.9% and a 60.8% success rate. Peters covers the Financial sector, focusing on stocks such as Marsh & Mclennan Companies, United Insurance Holdings, and Arthur J Gallagher & Co.
Health Insurance Innovations has an analyst consensus of Strong Buy, with a price target consensus of $69.17, which is a 97.6% upside from current levels. In a report issued on November 29, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $65 price target.
.
See today’s analyst top recommended stocks >>
Health Insurance Innovations’ market cap is currently $484.1M and has a P/E ratio of 33.48. The company has a Price to Book ratio of 5.29.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Health Insurance Innovations, Inc. engages in the distribtuion of individual and family health insurance plans. It offers short-term medical; accident, sickness, and hospital; ancillary; lifestyle and discount services; and dental insurance plans. The company was founded by Michael W. Kosloske in 2008 and is headquartered in Tampa, FL.
